Zynerba Pharmaceuticals Presents Sleep Data from Study of Zygel™ in Children and Adolescents with Both Developmental and Epileptic Encephalopathies (DEE) and Autism Spectrum Disorder (ASD) at the As
Go back to Zynerba Pharmaceuticals Presents Sleep Data from Study of Zygel™ in Children and Adolescents with Both Developmental and Epileptic Encephalopathies (DEE) and Autism Spectrum Disorder (ASD) at the As| (NASDAQ: ZYNE) | Delayed: 1.30 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.30 | 52 Week High | $21.56 | |||
| Open | $1.30 | 52 Week Low | $4.64 | |||
| Day High | $1.30 | P/E | N/A | |||
| Day Low | $1.30 | EPS | $0.00 | |||
| Volume | 1,051,902 | |||||
